Kaufman Rossin Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Kaufman Rossin Wealth's ABBV Position: Q3 2026 in Review
Kaufman Rossin Wealth increased its AbbVie (ABBV) stake by 70% in Q3 2026, buying an estimated $188K and bringing the position to 1,785 shares worth $467K. The position accounts for 0.19% of the portfolio, ranked #55.
Kaufman Rossin Wealth first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Kaufman Rossin Wealth held 1,785 shares of AbbVie worth $467K as of Q3 2026.
- Kaufman Rossin Wealth bought 733 AbbVie shares in Q3 2026, an estimated $188K.
- AbbVie made up 0.19% of Kaufman Rossin Wealth's portfolio in Q3 2026, its #55 holding.
- Kaufman Rossin Wealth first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Kaufman Rossin Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.